197 related articles for article (PubMed ID: 11502512)
1. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide.
Chicharro C; Granata C; Lozano R; Andreu D; Rivas L
Antimicrob Agents Chemother; 2001 Sep; 45(9):2441-9. PubMed ID: 11502512
[TBL] [Abstract][Full Text] [Related]
2. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide.
Díaz-Achirica P; Ubach J; Guinea A; Andreu D; Rivas L
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):453-60. PubMed ID: 9461543
[TBL] [Abstract][Full Text] [Related]
3. Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.
Luque-Ortega JR; Saugar JM; Chiva C; Andreu D; Rivas L
Biochem J; 2003 Oct; 375(Pt 1):221-30. PubMed ID: 12864731
[TBL] [Abstract][Full Text] [Related]
4. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
5. Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin.
Silva T; Abengózar MÁ; Fernández-Reyes M; Andreu D; Nazmi K; Bolscher JG; Bastos M; Rivas L
Amino Acids; 2012 Dec; 43(6):2265-77. PubMed ID: 22543751
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
7. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Lee MK; Kim KL; Hahm KS
J Pept Res; 1997 Oct; 50(4):279-85. PubMed ID: 9352466
[TBL] [Abstract][Full Text] [Related]
8. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
9. Conformation of the cecropin-melittin hybrid, cecropin A(1-8)-melittin (1-18) antibacterial Peptide.
Tauro S; Coutinho E; Srivastava S
Protein Pept Lett; 2004 Apr; 11(2):115-24. PubMed ID: 15078199
[TBL] [Abstract][Full Text] [Related]
10. Nucleation and growth of pores in 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) / cholesterol bilayer by antimicrobial peptides melittin, its mutants and cecropin P1.
Lyu Y; Fitriyanti M; Narsimhan G
Colloids Surf B Biointerfaces; 2019 Jan; 173():121-127. PubMed ID: 30278360
[TBL] [Abstract][Full Text] [Related]
11. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
12. The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation.
Arias C; Guizy M; Luque-Ortega JR; Guerrero E; de la Torre BG; Andreu D; Rivas L; Valenzuela C
Biochim Biophys Acta; 2006 Jan; 1763(1):110-9. PubMed ID: 16377003
[TBL] [Abstract][Full Text] [Related]
13. Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.
Pérez-Cordero JJ; Lozano JM; Cortés J; Delgado G
Peptides; 2011 Apr; 32(4):683-90. PubMed ID: 21262294
[TBL] [Abstract][Full Text] [Related]
14. Halictine-2 antimicrobial peptide shows promising anti-parasitic activity against Leishmania spp.
Pitale DM; Kaur G; Baghel M; Kaur KJ; Shaha C
Exp Parasitol; 2020 Nov; 218():107987. PubMed ID: 32891601
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the leishmanicidal activity of antimicrobial peptides.
Luque-Ortega JR; Rivas L
Methods Mol Biol; 2010; 618():393-420. PubMed ID: 20094878
[TBL] [Abstract][Full Text] [Related]
16. Structural framework for the modulation of the activity of the hybrid antibiotic peptide cecropin A-melittin [CA(1-7)M(2-9)] by Nε-lysine trimethylation.
Díaz MD; de la Torre BG; Fernández-Reyes M; Rivas L; Andreu D; Jiménez-Barbero J
Chembiochem; 2011 Sep; 12(14):2177-83. PubMed ID: 21805551
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids.
Juvvadi P; Vunnam S; Merrifield EL; Boman HG; Merrifield RB
J Pept Sci; 1996; 2(4):223-32. PubMed ID: 9231329
[TBL] [Abstract][Full Text] [Related]
18. Design of novel analogue peptides with potent fungicidal but low hemolytic activity based on the cecropin A-melittin hybrid structure.
Lee DG; Park JH; Shin SY; Lee SG; Lee MK; Kim KL; Hahm KS
Biochem Mol Biol Int; 1997 Oct; 43(3):489-98. PubMed ID: 9352066
[TBL] [Abstract][Full Text] [Related]
19. Design of protease-resistant pexiganan enhances antileishmanial activity.
Kulkarni MM; Karafova A; Kamysz W; McGwire BS
Parasitol Res; 2014 May; 113(5):1971-6. PubMed ID: 24658630
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial peptides with antiprotozoal activity: current state and future perspectives.
Giovati L; Ciociola T; Magliani W; Conti S
Future Med Chem; 2018 Nov; 10(22):2569-2572. PubMed ID: 30499691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
